Search
Monday 22 June 2015
  • :
  • :

Pre-Market News Alert on: Williams Partners LP (NYSE:WPZ), Kimberly Clark Corp (NYSE:KMB), Orexigen Therapeutics, Pengrowth Energy Corp (USA) (NYSE:PGH)

On Friday, Shares of Williams Partners LP (NYSE:WPZ), lost -1.33% to $ 53.25.

Williams Partners LP (NYSE:WPZ), declared that its Board of Directors has authorized a process to explore a range of planned alternatives following receipt of an unsolicited proposal to acquire Williams in an all-equity transaction at a stated per share price of $64.00. The unsolicited proposal was contingent on the termination of Williams’ pending acquisition of Williams Partners.

With the assistance of its outside financial and legal advisors, the Williams Board carefully considered the unsolicited proposal and determined that it significantly undervalues Williams and would not deliver value commensurate with what Williams anticipates to achieve on a standalone basis and through other growth initiatives, counting the pending acquisition of Williams Partners.

Williams Partners L.P., an energy infrastructure company, focuses on connecting North America’s hydrocarbon resource plays to growing markets for natural gas and natural gas liquids (NGL).

Shares of Kimberly Clark Corp (NYSE:KMB), declined -0.36% to $ 108.81, during its last trading session.

As the category leader, Kleenex Facial Tissue has become an everyday essential for consumers around the globe. But it is so much more than a tool to wipe a nose or dry an eye – it’s a gesture of care that, given the chance, has the power to connect and uplift us all. Every day we’re presented with opportunities to show we care. Despite our best intentions, these moments often get overlooked. In fact, nearly 50 percent of people in the U.S. say they’ve missed an opportunity to show someone they care, especially when it comes to everyday moments, according to a recent survey commissioned by Kleenex brand. This June, Kleenex brand is demonstrating the importance of timely care through a multi-platform commercial program counting documentary-style videos featuring compelling, real-life stories of people showing meaningful gestures of care throughout the U.S., and proving that no matter how big or small the moment, the act of giving a Kleenex Facial Tissue to someone who needs one – whether it’s a stranger, someone we care about, or even ourselves – can equalize, connect and uplift us all.

“Our aim is to reframe the category and demonstrate the ability of Kleenex Facial Tissue to deliver real-time care to consumers who need it and prove that the simple gesture of handing someone a Kleenex Facial Tissue can change the course of someone’s day,” said Eric Higgs, General Manager, Kleenex Brand.

Kimberly-Clark Corporation, together with its auxiliaries, manufactures and markets personal care, consumer tissue, and K-C professional products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional.

At the end of Friday’s trade, Shares of Orexigen Therapeutics, Inc. (NASDAQ:OREX), gained 1.07% to $4.73.

Orexigen Therapeutics, declared that administration will take part in a fireside chat discussion at the JMP Securities Life Sciences Conference in New York. The discussion is planned for Tuesday, June 23rd at 4 p.m. Eastern Time. To listen to the live webcast or a replay of the discussion, please visit the Investors section of the Company’s website at www.orexigen.com. A replay will be accessible for 14 days after the event.

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity.

Finally, Pengrowth Energy Corp (USA) (NYSE:PGH), ended its last trade with -1.57% loss, and closed at $2.51.

Pengrowth, reported that production from the Lindbergh thermal project now exceeds the project’s nameplate capacity of 12,500 barrels per day (bbl/d). With all three well pads now on SAGD (steam assisted gravity drainage) production, the project is presently producing in excess of 13,000 bbl/d with an instantaneous steam oil ratio of 1.9. Installation of the remaining downhole electric submersible pumps (ESPs) was accomplished at the end of May and all producing wells now have ESPs in place. Production rates from the commercial project continue to enhance, tracking the performance of the two pilot well pairs which have now been on production for over three years and which have been integrated into the commercial project. The project remains on track with continued ramp-up of production predictable through the remainder of 2015, ultimately achieving production rates of 16,000 bbl/d by the end of the year.

In addition, construction and commissioning of the Husky sales line is predictable to be accomplished by the end of June. The completion of the sales line will provide additional transportation/marketing optionality for the company. Pengrowth anticipates to utilize both pipeline and rail to move production to markets in an effort to maximize revenues and netbacks.

Pengrowth Energy Corporation engages in the acquisition, development, exploration, and production of oil and natural gas assets in the Alberta, British Columbia, Saskatchewan, and Nova Scotia provinces in Canada. It primarily explores for crude oil, bitumen, natural gas, and natural gas liquids.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *